Magnetic Insight
Magnetic Insight has pioneered magnetic particle imaging (MPI), a new diagnostic and monitoring technology that transforms medical imaging. MPI provides unique information not available from current structural and metabolic imaging captured by CT, MRI, and nuclear medicine. MPI offers what no other modality can: the ability to directly monitor costly cell therapy cancer treatments to inform clinical decision making. Having started in the preclinical space by selling small animal products to leading universities worldwide, Magnetic Insight is now scaling up MPI technology for clinical use.
Join our team as we grow! Visit the Careers page for the latest employment opportunities at Magnetic Insight.
Interested in keeping up with everything MPI? Check out the News page for the latest happenings in the field.
For all other inquiries, contact us here.
Executive Leadership
Patrick Goodwill, PhD
Co-founder / CTO / Interim CEO
Dr. Goodwill has spent the last 9 years leading the development team in Magnetic Particle Imaging at UC Berkeley. In his role, he has designed and built five prototype MPI scanners, and developed the x-space reconstruction systems theory that enables quantitative, high-quality MPI images. Dr. Goodwill has a PhD in Bioengineering from UC Berkeley, and a B.S. and M.S. in Electrical Engineering from Stanford University. Prior to UC Berkeley, Dr. Goodwill designed microprocessors at Intel Corporation.
Patrick Goodwill, PhD
Co-founder / CTO / CEO
John Carl
COO
John Carl has 20 years of experience in developing life science tools. His broad experience includes leadership in operations, manufacturing, product development, and quality. He previously spent nearly 11 years at ProteinSimple developing and commercializing proteomics analysis systems, where he held director level roles in quality management, reagents manufacturing, and instrument manufacturing. More recently, he was the director of product development at Xcell Biosciences, where he led the development and manufacturing of next generation cell culture instrumentation. He holds a B.S. in Mechanical Engineering for UC Berkeley.
John Carl
COO
Board of Directors
Patrick Goodwill, PhD
Co-founder / CTO / CEO
Dr. Goodwill has spent the last 9 years leading the development team in Magnetic Particle Imaging at UC Berkeley. In his role, he has designed and built five prototype MPI scanners, and developed the x-space reconstruction systems theory that enables quantitative, high-quality MPI images. Dr. Goodwill has a PhD in Bioengineering from UC Berkeley, and a B.S. and M.S. in Electrical Engineering from Stanford University. Prior to UC Berkeley, Dr. Goodwill designed microprocessors at Intel Corporation.
Patrick Goodwill, PhD
Co-founder / CTO / CEO
Mike Harsh
Commercial Advisor, CTO GE Healthcare
Mr. Michael (Mike) Harsh is co-founder of Terapede Systems with over 36 years’ experience in healthcare technology, focused on diagnostic imaging. He served as Vice President and Chief Technology Officer for GE Healthcare, a $17 billion division of General Electric. As the Global Technology Leader of Imaging Technologies at GE Global Research, he led the research for X-Ray, CT, MRI, Ultrasound, Nuclear Medicine, PET and Optical Imaging, and the research associated with computer visualization/image analysis and superconducting systems. Mike was elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows, for his significant contributions to the medical and biological engineering field. Additionally, Mike holds numerous U.S. patents in the field of Medical Imaging and Instrumentation. Mike received a bachelor’s degree in Electrical Engineering from Marquette University, Milwaukee, Wisconsin, and he is a member of the University of Wisconsin Madison Industrial Advisory Board to the College of Engineering.
Mike Harsh
Commercial Advisor- Former, CTO GE Healthcare
Anna Christensen, PhD
Co-founder
Dr Christensen has spent the last 16 years commercializing platform technologies in imaging and diagnostics. Most recently, she led the in vivo imaging business for PerkinElmer Inc and Caliper Life Sciences as the global business leader. Prior to Caliper Life Sciences, she held senior management positions at DiscoverX and Molecular Devices. In addition to her commercial experience, she holds advanced degrees in cell biology and neurobiology from UC San Diego and Copenhagen University.
Anna Christensen, PhD
Co-founder
The Advisors
Steven Conolly, PhD
Co-founder, MPI Professor at UC Berkeley
Prof. Conolly is a the Montford Cook Professor of Bioengineering, Electrical Engineering, and Computer Science at the University of California Berkeley. He received his Ph.D. in Electrical Engineering from Stanford University, where he developed new types of MRI scanners for over twenty years. At Berkeley he has applied his knowledge of building new imaging systems to MPI. He has a history of innovation, and for his many inventions, he was named one of only 24 people named a Stanford Outstanding Inventor.
Steven Conolly, PhD
Co-founder, Professor, UC Berkeley
Max Wintermark MD
Medical Advisor, Chief Neuroradiology Stanford
Dr. Wintermark is currently a Professor of Radiology and the Chief of Neuroradiology at the Stanford University. His specific interest and expertise is in stroke, traumatic brain injury, epilepsy, movement disorders and psychiatric disorders. He chairs on the research committees for the American Society of Neuroradiology (ASNR), American Society of Functional Neuroradiology (ASFNR) and the imaging working group of the NINDS-funded stroke clinical trial network (StrokeNET).
Max Wintermark MD
Medical Advisor, Chief of Neuroradiology, Stanford